BioSpace News Archive

Nym Health, pioneers of Clinical Language Understanding (CLU) technology, today announced that Geisinger is deploying Nym’s autonomous medical coding technology to all nine of its hospital emergency departments.

Medline announced plans to manufacture face masks in North America for the first time.

RedHawk Holdings Corp. (OTC: SNDD) (“RedHawk” or the “Company”), a diversified holding company primarily engaged in sales and distribution of medical devices, announced today its financial results for the three months and fiscal year ended June 30, 2020 . For the three month period ended June 30, 2020 , on revenues of $916

The Medica EasyRA® benchtop clinical chemistry analyzer, distributed and serviced by Greensboro-based company, Carolina Liquid Chemistries Corp. (CLC), allows healthcare providers to test routine blood chemistries to include metabolic panels, liver enzymes, kidney function tests, glucose and cardiovascular tests.

Surgery Partners, Inc. announced that Wayne S. DeVeydt, Executive Chairman of the Board, Eric Evans, Chief Executive Officer and Tom Cowhey, Chief Financial Officer will participate in the 2nd Annual Wolfe Research Healthcare Conference on Thursday, November 19, 2020 at 9:00a.m..

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that management will participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference on Tuesday, December 1, 2020.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will participate in a fireside chat presentation for the Piper Sandler 32nd Annual Virtual Healthcare Conference.

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced a proposed underwritten public offering in which it intends to offer and sell, subject to market and other conditions, up to 2,500,000 shares of its common stock

Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that management will present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference on Wednesday, December 2, 2020 at 10:30 a.m. Eastern Time.

Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has named William Geist to the position of chief operating officer (COO), effective November 16, 2020.